Compare ELTK & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTK | ESLA |
|---|---|---|
| Founded | 1970 | 2021 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 60.9M |
| IPO Year | 1998 | N/A |
| Metric | ELTK | ESLA |
|---|---|---|
| Price | $8.31 | $1.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 3.7K | ★ 177.7K |
| Earning Date | 05-19-2026 | 05-26-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.18 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $48.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.73 | $0.78 |
| 52 Week High | $12.19 | $3.15 |
| Indicator | ELTK | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 68.48 |
| Support Level | $7.79 | $1.41 |
| Resistance Level | $9.34 | $2.18 |
| Average True Range (ATR) | 0.37 | 0.24 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 54.89 | 77.06 |
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.